GMWatch mythbuster exposes UK government misinformation on gene editing
By GMWatch Staff,
GMWatch
| 02. 16. 2021
UK farm and environment ministry DEFRA published an “Explainer” document on gene editing as a guide for members of the public who want to respond to the UK government’s consultation on its plan to deregulate gene editing. It may also have been meant to assist the media, as parts of the text also occur in DEFRA’s press release for the launch of the public consultation.
Just over three weeks into the consultation the “Explainer” suddenly seemed to disappear from DEFRA’s website, possibly as a result of complaints.
There is certainly plenty to complain about. The “Explainer” is packed full of false assertions and reads like a “wish list” for the GMO lobby, presenting hypothetical “benefits” of gene editing as fact. The Cabinet Office Consultation Principles stipulate that “Consultations should be informative. Give enough information to ensure that those consulted understand the issues and can give informed responses”. They should “include validated impact assessments of the costs and benefits of the options being considered when possible".
But the information presented in the "Explainer" is extremely biased and only presents one side...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...